Form D/A — 65 Therapeutics, Inc.

0002047647-26-000002 · filed Jul 6, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Reported offering amount: $6,700,000
Reported amount sold: $6,700,000
Minimum investment: $0
Investors: 2
Sales commission: $0
Finders' fees: $0

Issuer

Name: 65 Therapeutics, Inc.
CIK: 2047647
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2024
Address: 399 REVOLUTION DRIVE
SOMERVILLE, MA 02145
Phone: 617-784-9147

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Julius Knowles · Executive Officer

Somerville, MA Find on LinkedIn ↗
Murthy Chavali · Director

Somerville, MA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗